\(5-HT_{2A/2C}\) antagonist used in migraine
Methysergide is a serotonin receptor antagonist primarily targeting the \(5-HT_{2A}\) and \(5-HT_{2C}\) receptors. It has been used as a prophylactic treatment for migraine by preventing vasoconstriction and platelet aggregation associated with migraine attacks. - Methysergide blocks serotonin-induced vasoconstriction, thereby reducing migraine frequency.
- Ketanserin is also a \(5-HT_{2}\) antagonist but primarily used as an antihypertensive agent.
- Sumatriptan and Rizatriptan are \(5-HT_{1B/1D}\) receptor agonists (triptans) used for acute migraine treatment, not antagonists.
Hence, Methysergide is the correct drug categorized as a \(5-HT_{2A/2C}\) antagonist used in migraine prophylaxis.
List - I | List - II |
---|---|
A) Morphine | IV) Pain killer |
B) Cannabinoids | V) Dopamine |
C) Cocaine | I) Cardiovascular system |
D) Benzodiazepines | II) Tranquilizers |
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil